![](/img/cover-not-exists.png)
PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE
D Zou, O Desjardins, N Tsao, R GoereeVolume:
13
Year:
2010
Language:
english
DOI:
10.1016/s1098-3015(10)72617-6
File:
PDF, 76 KB
english, 2010